Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

HTI

Halozyme Therapeutic (HTI)

Halozyme Therapeutics
일자:
정렬 기준:
 검색 관련기사 보기:AMEX:HTI
일자시간출처헤드라인심볼기업
2007/05/0722:00PR Newswire (US)Halozyme Therapeutics to Hold Business Update Conference Call on May 11AMEX:HTIHalozyme Therapeutics
2007/05/0222:00PR Newswire (US)Halozyme Therapeutics to Present at May Investment ConferencesAMEX:HTIHalozyme Therapeutics
2007/05/0222:00PR Newswire (US)Halozyme Therapeutics to Present at May Investment ConferencesAMEX:HTIHalozyme Therapeutics
2007/04/3022:00PR Newswire (US)Halozyme Therapeutics Announces Nasdaq Global Market Listing ApprovalAMEX:HTIHalozyme Therapeutics
2007/04/2723:00PR Newswire (US)Baxter Introduces HYLENEX for Use in Ophthalmic SurgeryAMEX:HTIHalozyme Therapeutics
2007/04/2422:00PR Newswire (US)Halozyme Therapeutics Announces $32.1 Million Private FinancingAMEX:HTIHalozyme Therapeutics
2007/03/1407:00PR Newswire (US)Halozyme Therapeutics Adopts SEC Rule 10b5-1 PolicyAMEX:HTIHalozyme Therapeutics
2007/03/0822:00PR Newswire (US)Halozyme Therapeutics Reports Fourth Quarter and Year End 2006 Financial ResultsAMEX:HTIHalozyme Therapeutics
2007/03/0722:00PR Newswire (US)Halozyme Therapeutics to Present at the Cowen & Company 27th Annual Health Care ConferenceAMEX:HTIHalozyme Therapeutics
2007/03/0622:00PR Newswire (US)Halozyme Therapeutics to Hold 2006 Fourth Quarter and Year End Conference Call on March 8AMEX:HTIHalozyme Therapeutics
2007/02/1506:31PR Newswire (US)Halozyme Therapeutics and Baxter Present Promising Results for the Use of HYLENEX From the Infuse-Morphine StudyAMEX:HTIHalozyme Therapeutics
2007/02/1422:00PR Newswire (US)Halozyme and Baxter Expand Global HYLENEX CollaborationAMEX:HTIHalozyme Therapeutics
2007/02/1322:00PR Newswire (US)Halozyme therapeutics to Present at the Roth Capital Partners 19th Annual OC ConferenceAMEX:HTIHalozyme Therapeutics
2007/01/2222:00PR Newswire (US)Halozyme Therapeutics Releases Results of Enhanze Technology Clinical Trial to Improve the Subcutaneous Absorption of a Large PrAMEX:HTIHalozyme Therapeutics
2007/01/0322:00PR Newswire (US)Halozyme Therapeutics to Present at the JPMorgan 25th Annual Healthcare ConferenceAMEX:HTIHalozyme Therapeutics
2006/12/0607:48PR Newswire (US)Halozyme and Roche Enter Agreement for the Application of Enhanze, A Novel Technology to Improve Drug DeliveryAMEX:HTIHalozyme Therapeutics
2006/11/2722:00PR Newswire (US)Halozyme Therapeutics Completes Enrollment of Enhanze Technology Clinical Trial to Improve the Subcutaneous Absorption of a LargAMEX:HTIHalozyme Therapeutics
2006/11/2722:00PR Newswire (US)Halozyme Therapeutics Completes Enrollment of Enhanze Technology Clinical Trial to Improve the Subcutaneous Absorption of a LargAMEX:HTIHalozyme Therapeutics
2006/11/2022:00PR Newswire (US)Halozyme Therapeutics to Present at the Lazard Capital Markets Third Annual Life Sciences ConferenceAMEX:HTIHalozyme Therapeutics
2006/11/2022:00PR Newswire (US)Halozyme Therapeutics to Present at the Lazard Capital Markets Third Annual Life Sciences ConferenceAMEX:HTIHalozyme Therapeutics
2006/11/1006:05PR Newswire (US)Halozyme Therapeutics Reports Third Quarter 2006 Financial ResultsAMEX:HTIHalozyme Therapeutics
2006/11/1006:05PR Newswire (US)Halozyme Therapeutics Reports Third Quarter 2006 Financial ResultsAMEX:HTIHalozyme Therapeutics
2006/11/0906:00PR Newswire (US)Halozyme Therapeutics Names William Fallon Vice President, Manufacturing & OperationsAMEX:HTIHalozyme Therapeutics
2006/11/0203:55PR Newswire (US)Halozyme Therapeutics to Present at the Rodman and Renshaw 8th Annual Healthcare ConferenceAMEX:HTIHalozyme Therapeutics
2006/10/2622:00PR Newswire (US)New Survey Reveals Most Patients Are Unaware That Slaughterhouse-Derived Animal Products Are Used in a Majority of IVF ProcedureAMEX:HTIHalozyme Therapeutics
2006/10/1222:00PR Newswire (US)Halozyme Therapeutics to Present at the 2006 Bio InvestorForumAMEX:HTIHalozyme Therapeutics
2006/10/1022:00PR Newswire (US)Halozyme Therapeutics Completes Enrollment of Infuse-Morphine Clinical TrialAMEX:HTIHalozyme Therapeutics
2006/09/1922:00PR Newswire (US)Halozyme Therapeutics to Present at the Noble Financial Small Cap ConferenceAMEX:HTIHalozyme Therapeutics
2006/09/1322:00PR Newswire (US)Halozyme Therapeutics Completes Call of Second Tranche of Warrants From January 2004 FinancingAMEX:HTIHalozyme Therapeutics
2006/08/2922:00PR Newswire (US)Halozyme Therapeutics to Present at the Roth 2006 New York ConferenceAMEX:HTIHalozyme Therapeutics
 검색 관련기사 보기:AMEX:HTI